Bernstein Reduces Firm's PT on Insulet (PODD) Stock [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
On January 9, Bernstein analyst Lee Hambright reduced the firm's price objective on Insulet Corporation (NASDAQ:PODD)'s stock to $380 from $410, while keeping an “Outperform” rating, as reported by The Fly. As per the firm, after a low point in September 2025, the US healthcare stocks are now performing well over the past couple of months. The firm expects better days ahead for the healthcare stocks in 2026 as the market gets more clarity on numerous macro/policy uncertainties. Elsewhere, on January 9, Goldman Sachs analyst David Roman reduced the firm's price objective on Insulet Corporation (NASDAQ:PODD)'s stock to $365 from $388, while keeping a “Buy” rating, as reported by The Fly. As per the analyst, after a year when fundamentals diverged from stock performance, 2026 is expected to demonstrate a return to normalized patterns, wherein organic growth explains relative valuation. Insulet Corporation (NASDAQ:PODD) is engaged in developing, manufacturing, and selling insulin de
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- JPM26: Insulet presents optimistic growth plan heading into 2026 [Yahoo! Finance]Yahoo! Finance
- Insulet (NASDAQ:PODD) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $274.00 price target on the stock.MarketBeat
- Why Analysts See The Insulet (PODD) Story Shifting As Omnipod Growth Meets Valuation Questions [Yahoo! Finance]Yahoo! Finance
- Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 [Yahoo! Finance]Yahoo! Finance
- Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.MarketBeat
PODD
Earnings
- 11/6/25 - Beat
PODD
Sec Filings
- 1/6/26 - Form 4
- 1/6/26 - Form 4
- 12/19/25 - Form 8-K
- PODD's page on the SEC website